Gunter Bernhardt

Carl Neuberg Street 1
Hannover, NI 30625, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications

Omicron infection-associated T- and B-cell immunity in antigen-naive and triple-COVID-19-vaccinated individuals.

Omicron infection-associated T- and B-cell immunity in antigen-naive and triple-COVID-19-vaccinated individuals.

Journal: Frontiers in immunology
Published: February 15, 2023

Establishment and Functional Characterization of Murine Monoclonal Antibodies Recognizing Neuritin.

Establishment and Functional Characterization of Murine Monoclonal Antibodies Recognizing Neuritin.

Journal: Antibodies (Basel, Switzerland)
Published: January 13, 2023

TIGIT mediates activation-induced cell death of ILC2s during chronic airway allergy.

TIGIT mediates activation-induced cell death of ILC2s during chronic airway allergy.

Journal: The Journal of experimental medicine
Published: November 23, 2022

Healthy-like CD4+ Regulatory and CD4+ Conventional T-Cell Receptor Repertoires Predict Protection from GVHD Following Donor Lymphocyte Infusion.

Healthy-like CD4+ Regulatory and CD4+ Conventional T-Cell Receptor Repertoires Predict Protection from GVHD Following Donor Lymphocyte Infusion.

Journal: International journal of molecular sciences
Published: August 21, 2022

Longitudinal Tracking of Immune Responses in COVID-19 Convalescents Reveals Absence of Neutralization Activity Against Omicron and Staggered Impairment to Other SARS-CoV-2 Variants of Concern.

Longitudinal Tracking of Immune Responses in COVID-19 Convalescents Reveals Absence of Neutralization Activity Against Omicron and Staggered Impairment to Other SARS-CoV-2 Variants of Concern.

Journal: Frontiers in immunology
Published: January 26, 2022

BNT162b2-boosted immune responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination against COVID-19.

BNT162b2-boosted immune responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination against COVID-19.

Journal: Nature communications
Published: December 24, 2021

Identification of Follicular T Cells in the Gut.

Identification of Follicular T Cells in the Gut.

Journal: Methods in molecular biology (Clifton, N.J.)
Published: November 21, 2021

Robust induction of neutralizing antibodies against the SARS-CoV-2 Delta variant after homologous Spikevax or heterologous Vaxzevria-Spikevax vaccination.

Robust induction of neutralizing antibodies against the SARS-CoV-2 Delta variant after homologous Spikevax or heterologous Vaxzevria-Spikevax vaccination.

Journal: European journal of immunology
Published: September 20, 2021

Neutralization of the SARS-CoV-2 Delta variant after heterologous and homologous BNT162b2 or ChAdOx1 nCoV-19 vaccination.

Neutralization of the SARS-CoV-2 Delta variant after heterologous and homologous BNT162b2 or ChAdOx1 nCoV-19 vaccination.

Journal: Cellular & molecular immunology
Published: July 29, 2021

The impact of stress on the transcriptomic signature of iNKT1 cells.

The impact of stress on the transcriptomic signature of iNKT1 cells.

Journal: Biochemistry and biophysics reports
Published: July 29, 2021

Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination.

Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination.

Journal: Nature medicine
Published: June 01, 2021

Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methods.

Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methods.

Journal: Cellular & molecular immunology
Published: July 24, 2020
Showing 1-12 of 37

Last Updated: 09/26/2026